Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120220370300235
Journal of Korean Medical Science
2022 Volume.37 No. 30 p.235 ~ p.235
The Risk of Gastrointestinal Cancer on Daily Intake of Low-Dose BaP in C57BL/6 for 60 Days
Zheng Zhi

Park Jung-Kuk
Kwon Oh-Wook
Ahn Sung-Hoon
Kwon Young-Joo
Jiang Linjuan
Zhu Shaohui
Park Byoung-Hee
Abstract
Background: Benzo(a)pyrene (BaP) is a carcinogenic compound in contaminated foodstuffs. The effect of oral intake of the environmental carcinogen BaP under low doses and frequent exposure on a digestive system has not been thoroughly verified.

Methods: In this regard, this study was conducted to prove the toxicity effects of BaP on the stomach and colon tissue after exposure to C57BL/6 mouse (3 and 6 ¥ìg/kg) following daily oral administration for 60 days. This study investigated acute gastric mucosal injury, severe gastric edema, cell infiltration, and mononuclear cells, multifocal cells, and tumoral inflammatory cells.

Results: The results of ELISA showed that the expression of serum interleukin (IL)-6 and tumor necrosis factor-¥á in the BaP exposure group were significantly increased, and a high level of DNA adduct distribution in their stomach and colon. Moreover, this study has confirmed the expression of early carcinogenesis markers: nuclear factor (NF)-¥êB, p53, IL-6, superoxide dismutase 1 (SOD1), mucin (MUC1 and MUC2), and ¥â-catenin in the stomach and colon, and showed that there was a significant increase in IL-6, NF-¥êB, SOD1, ¥â-catenin, and MUC1 (P < 0.05). At the same time, there was a significant decrease in MUC2 and p53 (P < 0.05). Thus, even in low doses, oral intake of BaP can induce DNA damage, increasing the potential risk of gastrointestinal cancer.

Conclusion: This study will provide a scientific basis for researching environmental contaminated food and intestinal health following daily oral administration of BaP.
KEYWORD
Benzo(a)pyrene, Gastrointestinal Cancer, Oral Intake, Low-Dose, p53, MUC
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø